Question 1

Has Philip Filippis, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $367 in general payments to Philip Filippis, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Philip Filippis, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Philip Filippis, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Astellas Pharma US Inc	4	$353
Merck	1	$14

Drug	Claims	Cost to plans & patients
ErtapenemErtapenem Sodium	23	$8,347
Fosfomycin Tromethamine	37	$4,238
Daptomycin	24	$4,013
Meropenem	27	$2,708
Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod	17	$1,610
Sodium Chloride0.9 % Sodium Chloride	78	$862
Cefazolin Sodium	14	$319

Philip Filippis, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other infectious disease in Wayne